Module 3.3.1 (Pharmacological Treatment of Myasthenia Gravis) Flashcards

1
Q

What is the general MOA of immunosuppressants for the treatment of MG?

A

Improves muscle strength by suppressing abnormal antibodies

  • Suppresses IgGI and IgG3
  • Binding of AChR antibodies to AChR which result in impairment of neuromuscular transmission –> doesn’t occur anymore
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the MOA and site of action for the following immunosuppressants;

A) Glucocorticoid

B) Azathioprine

C) Mycophenolate mofetil

D) Cyclosporine

E) Tacrolimus

A

A)

  • Glucocorticoid response elements in DNA
  • Regulate gene transcription

B)

  • DNA
  • False nucleotide incorporation

C)

  • Inosine monophosphate dehydrogenase –> inhibits IMPDH

D)

  • Calcineurin inhibitor –> inhibits phosphatase activity

E)

  • Calcineurin inhibitor –> inhibits phosphatase activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Whats an example of Plasmapheresis Immunoglobulin? How does it help treat MG?

A

IV Ig

  • Removes destructive antibodies by binding to circulating autoantibodies
  • Inhibition of destruction of junctional folds of the postsynaptic membrane
  • Increases the number of AChRs at the NMJ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

For reversible inhibitors of anticholinesterases;

A) What is an example of a short-acting one?

B) What is an example of a medium-acting (injection) one?

C) what is an example of a medium-acting (oral) one?

A

A)

  • Edrophonium –> used for diagnosis of MG

B)

  • Neostigmine –> to reverse competitive neuromuscular block

C)

  • Neostigmine
  • Pyridostigmine

Both used orally in the treatment of myasthenia gravis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the general MOA of neostigmine and pyridostigmine (anticholinesterase)? Does it cross the BBB?

A

Indicated for the symptomatic management of MG

  • Inhibit acetylcholinesterase (AChE)
  • Prevent break down of ACh –> increased binding to the limited number of receptors due to increased concentration of endogenous ACh in the synapse
  • Improve neuromuscular transmission and increasing muscular contraction

does not cross BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is there enhancement of cholinergic transmission when neostigmine and pyridostigmine (anticholinesterase) is used?

A
  • Autonomic cholinergic synapses
  • Skeletal neuromuscular junction
  • CNS synapses

increase amount of ACH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some of the muscarinic effects on autonomic cholinergic synapses (anticholinesterases)?

A

Muscarinic effects (parasympathetic nervous system) of anticholinesterases are identical to those of direct-acting muscarinic agonists –> due to increased amount of acetylcholine at the synapse

  • Increased glandular secretion
  • Increase tone and motility of GI smooth muscle
  • Braydcardia
  • Bronchial constriction
  • Miosis (pupil constriction)
  • Decreased intraocular pressure
  • Urinary urgency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some of the effects on the neuromuscular junction (NMJ)(anticholinesterases)? What is it dependent on?

A

Effects of anticholinesterases at NMJ are dose dependent

  • Acting on nicotinic receptors
  • At therapeutic doses - increase in force of contraction

Toxic Doses

  • At toxic doses – reduction in force of contraction
  • Reduced contraction due to excessive amount of ACh at NMJ
  • Keep end-plate in a constant state of depolarisation
  • Cause depolarising neuromuscular blockade
  • Twitching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some of the effects on the CNS (anticholinesterases)? What is it dependent on?

A

Effects of anticholinesterases on the CNS is dose dependent

  • Therapeutic doses – produce mild stimulation, result in convulsion
  • Toxic doses – depress the CNS, respiratory depression
  • For CNS effects – needs to cross blood-brain barrier (BBB)
  • Tertiary compounds (physostigmine) and non-polar organophosphates cross BBB

> Neostigmine and pyridostigmine DO NOT cross BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the active sites of acetylcholine?

A
  • Catalytic site
  • Anionic site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

For edrophonium (short-acting anticholinesterase), where does it bind to? What is it used for and what are the effects of it?

A
  • Quaternary ammonium compound
  • Binds to anionic site of enzyme only
  • Ionic bond easily reversible
  • Very short acting
  • MAINLY use for differential diagnosis of myasthenia gravis
  • Briefly relieves weakness in myasthenia gravis involving the eye muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

For neostigmine and pyridostigmine (medium-acting anticholinesterase), where does it bind to? Why is it long-lasting?

A
  • Binds at both anionic and catalytic sites –> reversible
  • Acts as a substrate for AChE, like Ach –> increases Ach levels
  • Hydrolysis of the carbamylated enzyme is slow (minutes) compared to Ach (milliseconds)
  • Long-lasting effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Summarise the 3 different forms of reversible anticholinesterases

A

See attached image

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does myasthenia gravis damage/destroy acetylcholine receptors?

A

By complement fixation or by inducing the muscle cell to eliminate the receptors through endocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a cholinergic crisis? Examples (DUMBBELLS)

Pyridostigmine and neostigmine when used within therapeutic dose –> less likely to cause a cholinergic crisis

A

Excessive muscarinic stimulation –> respiratory depression (results from neuromuscular blockade and CNS depression)

  • D - Diarrhoea
  • U - Urination
  • M - Miosis (constriction of the pupil of the eye)
  • B - Bradycardia (slow heart beat)
  • B - Bronchospasm (difficulty breathing)
  • E - Emesis and Excitation of skeletal muscle
  • L - Lacrimation (excessive tear production)
  • L - Lethargy (fatigue)
  • S - Salivation (excessive drooling)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the treatment options for a cholinergic crisis?

A
  • IV Atropine (muscarinic antagonist) –> eradicates muscarinic effects of anticholinesterases
  • Respiratory depression needs mechanical ventilation
  • Suctioning required if atropine fails to reduce mucus secretion
17
Q

What are some examples of neuromuscular blocker drugs?

A

Competitive NMJ-blocking drugs

  • Atracurium
  • Cisatracurium

competes with acetylcholine for nicotinic receptors

Depolarising NMJ-blocking drugs (no depolarisation –> leads to paralysis)

  • Suxamethonium